Tonix Pharmaceuticals (TNXP) and MapLight Therapeutics (MPLT) traded higher on Thursday after Raymond James launched their coverage, issuing Strong Buy recommendations, with $26 and $46 per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results